RBI Surprises with 25 bps Rate Cut to 625 Nomura Warns Policy Framework Diluted Bank Nifty Underperforms Nifty 50 as Analysts Eye Selective PSU Bank Opportunities Amid Margin Pressures Windex Misuse Could Lead to Costly Damages What Consumers Should Avoid Truist Raises Flywire Price Target After Strong Q1 Revenue Beat and Guidance Boost Reliance Industries Sets AGM for June 19 Market Eyes Jio IPO Clarity First Trust ETFs Attract 406 Million in Inflows ETF League Tables Show DMLP Q4 2024 Earnings EPS of 024 Reported Amid Stock Decline FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment Mercury General MCY Q1 2026 Earnings Massive EPS Surprise on Strong Underwriting Yet Shares Edge Lower Loews Corporation Q1 2026 Earnings EPS of 163 Driven by Diversified Portfolio Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures Archer Aviation ACHR Q1 2026 Earnings NarrowerthanExpected Loss Amid PreRevenue Progress Gildan Activewear GIL Holds Steady Near 58 as Support and Resistance Levels Come into Focus Indigo Acquisition Corp Unit INACU Holds Steady Near Trust Value Amid Limited Trading Activity Omega Healthcare Investors Slides 106 as Support Levels Come into Focus Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces BGSF Inc BGSF Slides 323 as Selling Pressure Intensifies Below Resistance Prediction Market Suggests SpaceX OpenAI and Anthropic Could Command FirstDay Valuations Above 14 Trillion RYTHM Inc RYM Q3 2022 Earnings Deep EPS Miss Reflects Ongoing Operational Challenges Blackrock MuniYield Quality Fund III MYI Gains 115 as Muni Bond Sentiment Improves PD Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick BANX Q4 2022 Earnings EPS Slightly Misses Estimates Amid Challenging Market Conditions DLPN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Edges Higher Prudential Financial PRU Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Signals Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline ANGX Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty